Open Access

In vitro culture of Echinococcus multilocularis producing protoscoleces and mouse infection with the cultured vesicles

Parasites & Vectors20169:411

https://doi.org/10.1186/s13071-016-1687-y

Received: 3 April 2016

Accepted: 7 July 2016

Published: 25 July 2016

Abstract

Background

Alveolar echinococcosis (AE) is a lethal zoonosis caused by the fox-tapeworm Echinococcus multilocularis. The disease is difficult to treat and an effective therapeutic drug is urgently needed. Reliable models are essential for drug development. In this study, we developed both in vitro and in vivo models of larval E. multilocularis.

Results

The protoscoleces (PSC) of E. multilocularis from jirds were successfully cultured in a modified RPMI1640 based medium containing 25 % (v/v) fetal bovine serum (FBS). After 100 days of culture, PSC developed to larval vesicles (small unilocular cysts) and the fast growing vesicles produced PSC in brood capsules. In addition, mice were intraperitoneally injected with 30 cultured small vesicles and 100 % of the mice had resulting metacestode masses.

Conclusions

Larval protoscoleces and vesicles of E. multilocularis grow healthily in vitro in the RPMI1640 based medium containing 25 % FBS. Echinococcus multilocularis in vitro and in vivo models provide a valuable platform for investigating the biology of the parasite and screening effective therapeutic drugs against AE.

Keywords

Echinococcus multilocularis ProtoscolecesVesiclesIn vitro cultureAnimal model

Background

Alveolar echinococcosis (AE) is one of the most lethal helminthic infections in humans [1]. The disease is caused by the fox-tapeworm Echinococcus multilocularis, which occurs in most areas of the northern hemisphere [2, 3]. Recent epidemiological studies showed that AE is highly endemic in Central Asia, including western China, Kazakhstan and Kyrgyzstan [4, 5]. AE is a chronic parasitic disease and can remain asymptomatic in a patient for up to 15 years [6]. When an AE patient feels ill and requests to see a doctor, it is normally at a late stage. In this late stage, the parasite causes liver damage through its production of an infiltrating structure consisting of numerous small vesicles embedded in stroma of connective tissue, which makes surgical resection difficult and secondary re-infection often occurs [7]. Normally, surgical removal, if applicable, is the only curative method for treating AE and patients have to take albendazole (ABZ) and/or mebendazole (MBZ) after surgical treatment for at least 2 years [8]. Inoperable AE patients must undergo long term, often life-long, chemotherapy with ABZ and/or MBZ [9, 10]. Recent study has shown that these drugs are not parasiticidal in vivo against AE, and only inhibit E. multilocularis growth. This is the reason that AE patients have to take the drugs for a long time [11]. In addition, the occurrence of side effects with these drugs has been often reported, leading to discontinuation of treatment or to progressive disease. An effective therapeutic drug for AE is urgently needed.

Metacestodes of E. multilocularis are fluid-filled grape-like vesicles. The asexually proliferating vesicles cause the disease and the vesicles have been used for drug screening [4, 12, 13]. A simple and stable method for culturing the metacestodes of the parasite will be beneficial not only for biological and physiological studies, but also for speeding up drug development against AE. Several previous studies have achieved successful cultivation of E. multilocularis metacestodes in vitro. The co-culture system contains host support or feeder cells for the parasite to be maintained in medium for the several months required to produce PSC. Without the feeder cells, the metacestodes can be only maintained for a few weeks [1416].

In the present study, we cultured PSC of E. multilocularis in a modified medium without host feeder cells. In the culture system, PSC re-differentiate into vesicles which can be maintained for more than 100 days and the fast growing vesicles produced PSC in brood capsules.

Methods

Animal infections and parasites

Mongolian jirds (Meriones unguiculatus) were used for maintaining larval E. multilocularis in an animal house at the Veterinary Research Institute, Xinjiang Academy of Animal Science. Jirds were intraperitoneally (i.p.) infected with PSC of E. multilocularis collected from Yili, Xinjiang, China. Pathogen-free female BALB/c mice, aged 6–8 weeks, were purchased from Beijing Vital River Laboratory Animal Technology Company Limited, and raised in the animal facility of the First Affiliated Hospital of Xinjiang Medical University.

Collection of protoscoleces and in vitro cultivation

Mongolian jirds were infected with PSC of E. multilocularis for 4–8 months, and those with a heavy infection were sacrificed with CO2 anaesthesia. Metacestode masses were collected from the peritoneal cavity of the infected jirds under aseptic conditions and then washed with sterile phosphate-buffered saline (PBS). After removal of possible host tissues, the masses were minced into small tissue pieces. The parasite tissues were then passed through a sterilized sieve (100 mesh sieve) by grounding with a glass pestle. The passed through parasite tissues containing PSC were washed five times with PBS containing 100 U/ml penicillin and 100 μg/ml streptomycin (PBS-PS) by placing the tube on the bench for 5 min to allow the PSC to sediment at room temperature. The sedimented PSC were digested with 1 % (w/v) pepsin (Sigma-Aldrich, Louis, MO, USA) at pH 2.0 (adjusted with 2 M HCl) in Hank's Buffer for 20 min at 37 °C. After the digestion procedure, the PSC were washed five more times with PBS-PS to remove debris by natural sedimentation for 5 min at room temperature. The viability of PSC was determined by staining with 0.1 % methylene blue, with dead PSC staining blue.

Only samples with ≥ 95 % viability were subsequently cultured in RPMI 1640 medium (Gibco, Auckland, New Zealand) containing 25 % (v/v) FBS (Gibco), 0.45 % (w/v) yeast extract, 0.4 % (w/v) of glucose, 100 U/ml penicillin and 100 μg/ml streptomycin in a culture flask at 37 °C in the presence of 5 % CO2. The medium was changed every 3 days. Each culture was monitored weekly under an optical microscope to check the growth status of the larval vesicles.

Animal infection

BALB/c mice were each i.p. transplanted with 30 small (250–300 μm in diameter) cultured vesicles of E. multilocularis. After 6 months, parasitic masses were collected from the mice and histopathological examination was performed by hematoxylin and eosin staining.

Results and discussion

The genotype of the E. multilocularis Xinjiang Yili isolate used in this study was determined by sequencing the mitochondrial cytochrome c oxidase subunit 1 (cox1) gene. The sequence alignment showed 99.8 % identity to the sequence (gi261399263) of an E. multilocularis isolate collected in Kazakhstan (data not shown). On the first day of cultivation, we observed the culture contained 60 % of invaginated and 40 % evaginated PSC. The larval parasites had an even and smooth edge with clearly distinct internal and external structures/organs evident, including a rostellum, hooks, suckers and calcareous corpuscles (Fig. 1a). After 7 days of cultivation, a majority (76 %) of the PSC were evaginated. The head and neck region of the evaginated PSC were expanded into a “swollen” shape (Fig. 1b). After 15 days, the PSC were clearly differentiated into pre-microvesicles with some internal and external structures evident. However, the hooks and calcareous corpuscles had gradually disappeared or had degenerated. Suckers were re-positioned on the surface of the pre-microvesicles (arrowed in Fig. 1c). After 60 days, most PSC were dead, with only about 10 % of the PSC having developed into microvesicles. At this time, a thin laminated layer was observed in most vesicles under the microscope (Fig. 1d). The vesicles could be seen by the naked eye at this stage. As the dead PSC were normally sedimented, the microvesicles were suspended by slightly shaking the culture flask. Thus, the suspended microvesicles were easily separated from the dead PSC by simply transferring the suspended vesicles into a fresh flask with a Pasteur pipette. The culture system supported the healthy growth of the vesicles for more than 100 days, when the small vesicles grew to a mean diameter of 2.8 mm (Fig. 2a). Staining of the sectioned vesicles with toluidine blue indicated the small vesicles had a laminated layer; the germinal layer was also clearly stained. In part of the germinal layer, some cells were aggregated, likely forming pre-brood capsules. Importantly, PSC were found in some brood capsules and each capsule contained more than one PSC including immature and mature PSC (Fig. 2b, c).
Fig. 1

Light microscopy image of E. multilocularis vesicles obtained from protoscoleces cultured in vitro on day 1 (a), day 7 (b), day 15 (c), and day 60 (d). Abbreviations: E-PSC, evaginated PSC; H, hooks; LL, laminated layer; I-PSC, invaginated PSC; PSC, protoscoleces; SU, suckers; S-PSC, “swollen” PSC. Scale-bars: 500 μm

Fig. 2

Protoscoleces cultured in vitro at day 100 (a) and toluidine blue staining of the vesicles (b, magnification: 100×; c, magnification: 400×). Vesicles obtained from in vitro culture showing a developed brood capsule containing mature and developing protoscoleces. Abbreviations: BC, brood capsule; Pre-BC, pre-brood capsule; PSC, protoscoleces

In order to establish an in vivo animal model, we transferred 30 of the small, 300–500 μm in diameter sized cultured vesicles intraperitoneally into each of 10 female BALB/c mice (weight, 18–22 g) using a method described previously [17]. The mice were sacrificed 6 months post-infection. The subsequent lesion tissue/masses were removed from the peritoneal cavity of the mice for weighing and histological analysis. All the mice were successfully infected with the E. multilocularis tissue lesions forming many large tumor-like structures. The mean weight of the metacestode masses was 10.06 ± 3.58 g per mouse. Histological staining showed that the vesicles possessed the typical structure of a metacestode with a germinal membrane, a laminated layer, and brood capsules with mature and immature PSC (Fig. 3). This successful infection indicated that the in vitro cultured vesicles could be used as seeds for further infecting mice for maintaining the parasite in the laboratory.
Fig. 3

Echinococcus multilocularis metacestode and protoscolex development in mice. Cultured small vesicles were transferred into the peritoneal cavity of mice. a Metacestode masses of E. multilocularis in a mouse. b Hematoxylin and eosin staining of E. multilocularis lesion tissue section on a slide. Abbreviations: BC, brood capsule; PSC, protoscoleces. Scale-bar: 10 μm

Several studies have described the establishment of an in vitro cultivation system for E. multilocularis metacestodes. The first attempts were undertaken in the 1990s by Hemphill & Gottstein [14] and Jura et al. [15] using co-cultivation of host feeder cells and metacestode vesicles (fibroblasts in the “tissue block” method of Hemphill et al.; metacestodes with hepatocytes in the presence of a collagen matrix forming “sandwich configuration” method of Jura et al.). Subsequently, Spiliotis et al. (2004) [16] developed an in vitro system for a long-term cultivation of E. multilocularis larvae which depended strictly on reducing and anaerobic conditions. However, the growth of metacestode vesicles and differentiation towards the protoscolex stage only occurred in culture medium that was pre-conditioned by hepatoma cells. In 2008, Spiliotis & Brehm [18] established a large-scale cultivation system which utilized homogenized metacestode tissue that was incubated in liquid culture together with rat hepatoma feeder cells. The disadvantage of these culture methods was the requirement for the continuous presence of host cells. However, in this study, we have described a simple method which involves a medium containing a large amount of FBS (25 %) which allows PSC to redifferentiate into vesicles. The generated vesicles were able to produce PSC in vitro in the absence of host feeder cells, indicating that the high concentration of FBS likely contains sufficient essential growth factors for PSC growth and proliferation/differentiation. The advantage of this procedure and its comparison with other methods are described in Table 1. To obtain host cell-free cultured parasites, we used two procedures to remove possible host contamination: digestion with pepsin and washing. Before culture, we digested the parasite materials with pepsin and then washed the preparation five times with PBS. We then cultured the larval parasites in a feeder cell-free medium for more than 100 days. To determine whether the culture system required a high concentration of FBS, we used a low concentration of FBS (10 %) in the culture medium. We found PSC/microvesicles could not be maintained for more than six weeks, indicating that a high concentration of FBS is a key factor for PSC growth and differentiation. The success of culturing PSC to vesicles which in turn produced PSC indicates that larval E. multilocularis can be maintained in culture vessels in vitro. In addition, we showed that RPMI1640 is better than other media, such as MEM, for promoting PSC differentiation and maintenance [19].
Table 1

A comparison of different conditions used for culturing E. multilocularis in vitro

 

Hemphill et al. [14]

Jura et al. [15]

Spiliotis et al. [16]

This study

Initial parasite material

Small tissue blocks/ vesicles

Homogenized parasite tissue

Small vesicles

protoscoleces

Adding feeder cells

Yesa

Yesb

Yesc

No

PSC formation

Yes

Yes

Yes

Yes

Culture time

Stopped at day 100

At least 2 months

Stopped at day 56

More than 100 days

aCulture medium: Initiated by first growing human cancer colon (CACO2) cells to confluency. Then RPMI 1640 containing 12 mM HEPES, 10 % FCS, 2 mM glutamine, penicillin (200 U/ml), streptomycin (200 μg/ml), fungizone (0.50 μg/ml) and 50 μM β-mercaptoethanol was added

bCulture medium: 10 % FBS, 9.6 mg prednisolone/ml, 0.014 mg glucagon/ml, 0.16 U insulin/ml, penicillin (200 U/ml) and streptomycin (200 μg/ml). Primary hepatocytes and parasitic tissues were both embedded in a collagen bilayer

cCulture medium: DMEM containing 100 U/ml penicillin G and 100 μg/ml streptomycin, 10 % FBS, different feeder cell lines, 0.01 % 2-mercaptoethanol, 100 μM L-cysteine and 10 μM bathocuproine disulfonic acid

Conclusions

We have developed a simple and practical in vitro culture method for generating vesicles from PSC of E. multilocularis which in turn produced PSC in vitro in the absence of host feeder cells. This successful development of vesicles in a host feeder cell-free cultivation system represents a useful model for investigating the biology of E. multilocularis and for screening drugs for treatment of alveolar echinococcosis. Furthermore, we have developed a method for the secondary infection of E. multilocularis by simply transferring the cultured vesicles into the peritoneal cavity of mice, which provides a valuable animal model for investigating parasite development and elucidating host-parasite interactions.

Abbreviations

AE, alveolar echinococcosis; ABZ, albendazole; BC, brood capsule; cox1, cytochrome c oxidase subunit 1; E-PSC, evaginated PSC; FBS, fetal bovine serum; H, hooks; i.p, intraperitoneally; I-PSC, invaginated PSC; LL, laminated layer; MBZ, mebendazole; PSC, protoscoleces; PBS, phosphate-buffered saline; Pre-BC, pre-brood capsule; S-PSC, “swollen” PSC; SU, suckers

Declarations

Acknowledgments

We thank Mr Tao Jiang and Mr Chun Zhang for their support for maintaining experimental rodent animals and E. multilocularis parasite.

Funding

The work was supported by the grants from the National Natural Science Foundation of China (31260272, U1303222).

Availability of data and material

Data supporting the conclusions of this article are included within the article.

Authors’ contributions

WH and ZW-B conceived and designed the experiments; WH and ZL performed the experiments; GB-P, ZZ-Z participated in animal model and sample collection; WH wrote the manuscript; ZW-B, LJ and DPMcM critically revised the manuscript. All authors have read and approved the final version of the manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

This study was conducted in accordance with the Chinese Laboratory Animal Administration Act (1988) and the study protocol was approved by the Ethical Committee of the First Affiliated Hospital of Xinjiang Medical University (Approval No IACUC-20120625003).

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
State Key Laboratory Incubation Base of Xinjiang Major Diseases Research, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University
(2)
Veterinary Research Institute, Xinjiang Academy of Animal Science
(3)
Molecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute

References

  1. Craig PS, Rogan MT, Allan JC. Detection, screening and community epidemiology of taeniid cestode zoonoses: cystic echinococcosis, alveolar echinococcosis and neurocysticercosis. Adv Parasitol. 1996;38:169–250.View ArticlePubMedGoogle Scholar
  2. Eckert J, Deplazes P. Alveolar echinococcosis in humans: the current situation in Central Europe and the need for countermeasures. Parasitol Today. 1999;15(8):315–9.View ArticlePubMedGoogle Scholar
  3. Stettler M, Fink R, Walker M, Gottstein B, Geary TG, Rossignol JF, Hemphill A. In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother. 2003;47(2):467–74.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Hemphill A, Stadelmann B, Scholl S, Muller J, Spiliotis M, Muller N, et al. Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes. Parasitology. 2010;137(3):569–87.View ArticlePubMedGoogle Scholar
  5. Zhang W, Zhang Z, Wu W, Shi B, Li J, Zhou X, et al. Epidemiology and control of echinococcosis in central Asia, with particular reference to the People's Republic of China. Acta Trop. 2015;141(Pt B):235–43.View ArticlePubMedGoogle Scholar
  6. McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet. 2003;362(9392):1295–304.View ArticlePubMedGoogle Scholar
  7. Gottstein B, Hemphill A. Immunopathology of echinococcosis. Chem Immunol. 1997;66:177–208.View ArticlePubMedGoogle Scholar
  8. McManus DP, Gray DJ, Zhang W, Yang Y. Diagnosis, treatment, and management of echinococcosis. BMJ. 2012;344, e3866.View ArticlePubMedGoogle Scholar
  9. Hemphill A, Muller J. Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options. J Helminthol. 2009;83(2):99–111.View ArticlePubMedGoogle Scholar
  10. Vuitton DA. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus? Expert Rev Anti Infect Ther. 2009;7(2):145–9.View ArticlePubMedGoogle Scholar
  11. Hemphill A, Spicher M, Stadelmann B, Mueller J, Naguleswaran, Gottstein B, Walker M. Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis. Parasitology. 2007;134(Pt 12):1657–70.PubMedGoogle Scholar
  12. Hemphill A, Stettler M, Walker M, Siles-Lucas M, Fink R, Gottstein B. Culture of Echinococcus multilocularis metacestodes: an alternative to animal use. Trends Parasitol. 2002;18(10):445–51.View ArticlePubMedGoogle Scholar
  13. Hemphill A, Stettler M, Walker M, Siles-Lucas M, Fink R, Gottstein B. In vitro culture of Echinococcus multilocularis and Echinococcus vogeli metacestodes: studies on the host-parasite interface. Acta Trop. 2003;85(2):145–55.View ArticlePubMedGoogle Scholar
  14. Hemphill A, Gottstein B. Immunology and morphology studies on the proliferation of in vitro cultivated Echinococcus multilocularis metacestodes. Parasitol Res. 1995;81(7):605–14.View ArticlePubMedGoogle Scholar
  15. Jura H, Bader A, Hartmann M, Maschek H, Frosch M. Hepatic tissue culture model for study of host-parasite interactions in alveolar echinococcosis. Infect Immun. 1996;64(9):3484–90.PubMedPubMed CentralGoogle Scholar
  16. Spiliotis M, Tappe D, Sesterhenn L, Brehm K. Long-term in vitro cultivation of Echinococcus multilocularis metacestodes under axenic conditions. Parasitol Res. 2004;92(5):430–2.View ArticlePubMedGoogle Scholar
  17. Zhang WB, Jones MK, Li J, McManus DP. Echinococcus granulosus: pre-culture of protoscoleces in vitro significantly increases development and viability of secondary hydatid cysts in mice. Exp Parasitol. 2005;110(1):88–90.View ArticlePubMedGoogle Scholar
  18. Brehm K, Spiliotis M. Recent advances in the in vitro cultivation and genetic manipulation of Echinococcus multilocularis metacestodes and germinal cells. Exp Parasitol. 2008;119(4):506–15.View ArticlePubMedGoogle Scholar
  19. Yuan LY, Zhang ZZ, Shi BX, Mi XY, Zhang L, Wang JC, et al. In vitro cultivation of the protoscolices of Echinococcus granulosus in medium RPMI-1640 and MEM. J Anim Sci Vet Med. 2008;27(5):16–8.Google Scholar

Copyright

© The Author(s). 2016

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement